Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ex Vivo LPS Stimulation in Healthy and Compromised Subjects

This study has been completed.
Sponsor:
Collaborators:
Unilever R&D
Netherlands Metabolomic Center (NMC), The Netherlands
Information provided by (Responsible Party):
W.J. Pasman, TNO Quality of Life
ClinicalTrials.gov Identifier:
NCT01656915
First received: June 20, 2012
Last updated: June 18, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)